世界の帯状疱疹後神経痛治療薬市場予測2023-2029:抗けいれん薬、抗うつ薬、オピオイド、その他

【英語タイトル】Post Herpetic Neuralgia Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23LY8587)・商品コード:MMG23LY8587
・発行会社(調査会社):Market Monitor Global
・発行日:2023年7月
・ページ数:71
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の帯状疱疹後神経痛治療薬市場規模と予測を収録しています。・世界の帯状疱疹後神経痛治療薬市場:売上、2018年-2023年、2024年-2029年
・世界の帯状疱疹後神経痛治療薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の帯状疱疹後神経痛治療薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗けいれん薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

帯状疱疹後神経痛治療薬のグローバル主要企業は、Depomed、 Pfizer、 Daiichi Sankyoなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、帯状疱疹後神経痛治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の帯状疱疹後神経痛治療薬市場:タイプ別、2018年-2023年、2024年-2029年
世界の帯状疱疹後神経痛治療薬市場:タイプ別市場シェア、2022年
・抗けいれん薬、抗うつ薬、オピオイド、その他

世界の帯状疱疹後神経痛治療薬市場:用途別、2018年-2023年、2024年-2029年
世界の帯状疱疹後神経痛治療薬市場:用途別市場シェア、2022年
・病院薬局、オンライン薬局、小売薬局

世界の帯状疱疹後神経痛治療薬市場:地域・国別、2018年-2023年、2024年-2029年
世界の帯状疱疹後神経痛治療薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における帯状疱疹後神経痛治療薬のグローバル売上、2018年-2023年
・主要企業における帯状疱疹後神経痛治療薬のグローバル売上シェア、2022年
・主要企業における帯状疱疹後神経痛治療薬のグローバル販売量、2018年-2023年
・主要企業における帯状疱疹後神経痛治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Depomed、 Pfizer、 Daiichi Sankyo

*************************************************************

・調査・分析レポートの概要
帯状疱疹後神経痛治療薬市場の定義
市場セグメント
世界の帯状疱疹後神経痛治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の帯状疱疹後神経痛治療薬市場規模
世界の帯状疱疹後神経痛治療薬市場規模:2022年 VS 2029年
世界の帯状疱疹後神経痛治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの帯状疱疹後神経痛治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の帯状疱疹後神経痛治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:抗けいれん薬、抗うつ薬、オピオイド、その他
帯状疱疹後神経痛治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院薬局、オンライン薬局、小売薬局
帯状疱疹後神経痛治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別帯状疱疹後神経痛治療薬市場規模 2022年と2029年
地域別帯状疱疹後神経痛治療薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Depomed、 Pfizer、 Daiichi Sankyo
...

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
This report aims to provide a comprehensive presentation of the global market for Post Herpetic Neuralgia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post Herpetic Neuralgia Drugs. This report contains market size and forecasts of Post Herpetic Neuralgia Drugs in global, including the following market information:
Global Post Herpetic Neuralgia Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Post Herpetic Neuralgia Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Post Herpetic Neuralgia Drugs companies in 2022 (%)
The global Post Herpetic Neuralgia Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Anticonvulsants Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Post Herpetic Neuralgia Drugs include Depomed, Pfizer and Daiichi Sankyo, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Post Herpetic Neuralgia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Post Herpetic Neuralgia Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Post Herpetic Neuralgia Drugs Market Segment Percentages, by Type, 2022 (%)
Anticonvulsants
Antidepressants
Opioids
Others
Global Post Herpetic Neuralgia Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Post Herpetic Neuralgia Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Global Post Herpetic Neuralgia Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Post Herpetic Neuralgia Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Post Herpetic Neuralgia Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Post Herpetic Neuralgia Drugs revenues share in global market, 2022 (%)
Key companies Post Herpetic Neuralgia Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Post Herpetic Neuralgia Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Depomed
Pfizer
Daiichi Sankyo
Outline of Major Chapters:
Chapter 1: Introduces the definition of Post Herpetic Neuralgia Drugs, market overview.
Chapter 2: Global Post Herpetic Neuralgia Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Post Herpetic Neuralgia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Post Herpetic Neuralgia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Post Herpetic Neuralgia Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Post Herpetic Neuralgia Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Post Herpetic Neuralgia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Post Herpetic Neuralgia Drugs Overall Market Size
2.1 Global Post Herpetic Neuralgia Drugs Market Size: 2022 VS 2029
2.2 Global Post Herpetic Neuralgia Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Post Herpetic Neuralgia Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Post Herpetic Neuralgia Drugs Players in Global Market
3.2 Top Global Post Herpetic Neuralgia Drugs Companies Ranked by Revenue
3.3 Global Post Herpetic Neuralgia Drugs Revenue by Companies
3.4 Global Post Herpetic Neuralgia Drugs Sales by Companies
3.5 Global Post Herpetic Neuralgia Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Post Herpetic Neuralgia Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Post Herpetic Neuralgia Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Post Herpetic Neuralgia Drugs Players in Global Market
3.8.1 List of Global Tier 1 Post Herpetic Neuralgia Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Post Herpetic Neuralgia Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Post Herpetic Neuralgia Drugs Market Size Markets, 2022 & 2029
4.1.2 Anticonvulsants
4.1.3 Antidepressants
4.1.4 Opioids
4.1.5 Others
4.2 By Type – Global Post Herpetic Neuralgia Drugs Revenue & Forecasts
4.2.1 By Type – Global Post Herpetic Neuralgia Drugs Revenue, 2018-2023
4.2.2 By Type – Global Post Herpetic Neuralgia Drugs Revenue, 2024-2029
4.2.3 By Type – Global Post Herpetic Neuralgia Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Post Herpetic Neuralgia Drugs Sales & Forecasts
4.3.1 By Type – Global Post Herpetic Neuralgia Drugs Sales, 2018-2023
4.3.2 By Type – Global Post Herpetic Neuralgia Drugs Sales, 2024-2029
4.3.3 By Type – Global Post Herpetic Neuralgia Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Post Herpetic Neuralgia Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Post Herpetic Neuralgia Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application – Global Post Herpetic Neuralgia Drugs Revenue & Forecasts
5.2.1 By Application – Global Post Herpetic Neuralgia Drugs Revenue, 2018-2023
5.2.2 By Application – Global Post Herpetic Neuralgia Drugs Revenue, 2024-2029
5.2.3 By Application – Global Post Herpetic Neuralgia Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Post Herpetic Neuralgia Drugs Sales & Forecasts
5.3.1 By Application – Global Post Herpetic Neuralgia Drugs Sales, 2018-2023
5.3.2 By Application – Global Post Herpetic Neuralgia Drugs Sales, 2024-2029
5.3.3 By Application – Global Post Herpetic Neuralgia Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Post Herpetic Neuralgia Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Post Herpetic Neuralgia Drugs Market Size, 2022 & 2029
6.2 By Region – Global Post Herpetic Neuralgia Drugs Revenue & Forecasts
6.2.1 By Region – Global Post Herpetic Neuralgia Drugs Revenue, 2018-2023
6.2.2 By Region – Global Post Herpetic Neuralgia Drugs Revenue, 2024-2029
6.2.3 By Region – Global Post Herpetic Neuralgia Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Post Herpetic Neuralgia Drugs Sales & Forecasts
6.3.1 By Region – Global Post Herpetic Neuralgia Drugs Sales, 2018-2023
6.3.2 By Region – Global Post Herpetic Neuralgia Drugs Sales, 2024-2029
6.3.3 By Region – Global Post Herpetic Neuralgia Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Post Herpetic Neuralgia Drugs Revenue, 2018-2029
6.4.2 By Country – North America Post Herpetic Neuralgia Drugs Sales, 2018-2029
6.4.3 US Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.4.4 Canada Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.4.5 Mexico Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Post Herpetic Neuralgia Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Post Herpetic Neuralgia Drugs Sales, 2018-2029
6.5.3 Germany Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.5.4 France Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.5.5 U.K. Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.5.6 Italy Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.5.7 Russia Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.5.9 Benelux Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Post Herpetic Neuralgia Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Post Herpetic Neuralgia Drugs Sales, 2018-2029
6.6.3 China Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.6.4 Japan Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.6.5 South Korea Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.6.7 India Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Post Herpetic Neuralgia Drugs Revenue, 2018-2029
6.7.2 By Country – South America Post Herpetic Neuralgia Drugs Sales, 2018-2029
6.7.3 Brazil Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.7.4 Argentina Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Post Herpetic Neuralgia Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Post Herpetic Neuralgia Drugs Sales, 2018-2029
6.8.3 Turkey Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.8.4 Israel Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Post Herpetic Neuralgia Drugs Market Size, 2018-2029
6.8.6 UAE Post Herpetic Neuralgia Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Depomed
7.1.1 Depomed Company Summary
7.1.2 Depomed Business Overview
7.1.3 Depomed Post Herpetic Neuralgia Drugs Major Product Offerings
7.1.4 Depomed Post Herpetic Neuralgia Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Depomed Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Post Herpetic Neuralgia Drugs Major Product Offerings
7.2.4 Pfizer Post Herpetic Neuralgia Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Daiichi Sankyo
7.3.1 Daiichi Sankyo Company Summary
7.3.2 Daiichi Sankyo Business Overview
7.3.3 Daiichi Sankyo Post Herpetic Neuralgia Drugs Major Product Offerings
7.3.4 Daiichi Sankyo Post Herpetic Neuralgia Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Daiichi Sankyo Key News & Latest Developments
8 Global Post Herpetic Neuralgia Drugs Production Capacity, Analysis
8.1 Global Post Herpetic Neuralgia Drugs Production Capacity, 2018-2029
8.2 Post Herpetic Neuralgia Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Post Herpetic Neuralgia Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Post Herpetic Neuralgia Drugs Supply Chain Analysis
10.1 Post Herpetic Neuralgia Drugs Industry Value Chain
10.2 Post Herpetic Neuralgia Drugs Upstream Market
10.3 Post Herpetic Neuralgia Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Post Herpetic Neuralgia Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Post Herpetic Neuralgia Drugs in Global Market
Table 2. Top Post Herpetic Neuralgia Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Post Herpetic Neuralgia Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Post Herpetic Neuralgia Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Post Herpetic Neuralgia Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Post Herpetic Neuralgia Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Post Herpetic Neuralgia Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Post Herpetic Neuralgia Drugs Product Type
Table 9. List of Global Tier 1 Post Herpetic Neuralgia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Post Herpetic Neuralgia Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Post Herpetic Neuralgia Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Post Herpetic Neuralgia Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Post Herpetic Neuralgia Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Post Herpetic Neuralgia Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Post Herpetic Neuralgia Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Post Herpetic Neuralgia Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Post Herpetic Neuralgia Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Post Herpetic Neuralgia Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Post Herpetic Neuralgia Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Post Herpetic Neuralgia Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Post Herpetic Neuralgia Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Post Herpetic Neuralgia Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Post Herpetic Neuralgia Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Post Herpetic Neuralgia Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Post Herpetic Neuralgia Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Post Herpetic Neuralgia Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Post Herpetic Neuralgia Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Post Herpetic Neuralgia Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Post Herpetic Neuralgia Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Post Herpetic Neuralgia Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Post Herpetic Neuralgia Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Post Herpetic Neuralgia Drugs Sales, (K Units), 2024-2029
Table 46. Depomed Company Summary
Table 47. Depomed Post Herpetic Neuralgia Drugs Product Offerings
Table 48. Depomed Post Herpetic Neuralgia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Depomed Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Post Herpetic Neuralgia Drugs Product Offerings
Table 52. Pfizer Post Herpetic Neuralgia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Daiichi Sankyo Company Summary
Table 55. Daiichi Sankyo Post Herpetic Neuralgia Drugs Product Offerings
Table 56. Daiichi Sankyo Post Herpetic Neuralgia Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Daiichi Sankyo Key News & Latest Developments
Table 58. Post Herpetic Neuralgia Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 59. Global Post Herpetic Neuralgia Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Post Herpetic Neuralgia Drugs Production by Region, 2018-2023 (K Units)
Table 61. Global Post Herpetic Neuralgia Drugs Production by Region, 2024-2029 (K Units)
Table 62. Post Herpetic Neuralgia Drugs Market Opportunities & Trends in Global Market
Table 63. Post Herpetic Neuralgia Drugs Market Drivers in Global Market
Table 64. Post Herpetic Neuralgia Drugs Market Restraints in Global Market
Table 65. Post Herpetic Neuralgia Drugs Raw Materials
Table 66. Post Herpetic Neuralgia Drugs Raw Materials Suppliers in Global Market
Table 67. Typical Post Herpetic Neuralgia Drugs Downstream
Table 68. Post Herpetic Neuralgia Drugs Downstream Clients in Global Market
Table 69. Post Herpetic Neuralgia Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Post Herpetic Neuralgia Drugs Segment by Type in 2022
Figure 2. Post Herpetic Neuralgia Drugs Segment by Application in 2022
Figure 3. Global Post Herpetic Neuralgia Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Post Herpetic Neuralgia Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Post Herpetic Neuralgia Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Post Herpetic Neuralgia Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Post Herpetic Neuralgia Drugs Revenue in 2022
Figure 9. By Type - Global Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Post Herpetic Neuralgia Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Post Herpetic Neuralgia Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Post Herpetic Neuralgia Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Post Herpetic Neuralgia Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Post Herpetic Neuralgia Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Post Herpetic Neuralgia Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Post Herpetic Neuralgia Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Post Herpetic Neuralgia Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Post Herpetic Neuralgia Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Post Herpetic Neuralgia Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Post Herpetic Neuralgia Drugs Sales Market Share, 2018-2029
Figure 23. US Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Post Herpetic Neuralgia Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Post Herpetic Neuralgia Drugs Sales Market Share, 2018-2029
Figure 28. Germany Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Post Herpetic Neuralgia Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Post Herpetic Neuralgia Drugs Sales Market Share, 2018-2029
Figure 37. China Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Post Herpetic Neuralgia Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Post Herpetic Neuralgia Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Post Herpetic Neuralgia Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Post Herpetic Neuralgia Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Post Herpetic Neuralgia Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Post Herpetic Neuralgia Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Post Herpetic Neuralgia Drugs by Region, 2022 VS 2029
Figure 54. Post Herpetic Neuralgia Drugs Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の帯状疱疹後神経痛治療薬市場予測2023-2029:抗けいれん薬、抗うつ薬、オピオイド、その他] (コード:MMG23LY8587)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の帯状疱疹後神経痛治療薬市場予測2023-2029:抗けいれん薬、抗うつ薬、オピオイド、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆